Market Research Insights

San Francisco, 26 July 2019:   The Report   Vaccine Contract Manufacturing Market   Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit, Toxoid, DNA), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), And Segment Forecasts, 2018 – 2025 The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries. Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and

San Francisco, 26 July 2019:   The Report   Medical Equipment Rental Market   Size, Share & Trends Analysis Report By End Use (Personal, Institutes, Hospitals), By Product (Storage & Transport, Durable, Surgical), And Segment Forecasts, 2018 – 2025 The global medical equipment rental market size is expected to reach USD 64.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.4% during the forecast period. Expanding base of geriatric and disabled population coupled with rising need for home healthcare products is propelling the market. Rising demand for technologically advanced clinical devices and increasing healthcare expenditure is encouraging R&D activities in the medical devices industry are resulting in launch of expensive variants of medical products. This is anticipated to positively influence the growth of the medical equipment rental market. Dominance of durable medical equipment (DME) can be attributed to in

San Francisco, 26 July 2019:   The Report   Viral Vector & Plasmid DNA Manufacturing Market  Analysis Report By Application, By Disease (Cancer, Genetic), By Workflow (Upstream, Downstream), By Vector, By End Use, And Segment Forecasts, 2019 – 2025 The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, according to a new report by Grand View Research, Inc., rising at a 16.0% CAGR during the forecast period. Rising number of gene therapy-based discovery programs in the pharma industry is one of the key trends driving the production of gene therapy vectors. Moreover, a robust pipeline of viral vaccines and gene therapies has prompted companies to develop novel and effective technologies for scalable manufacturing of vectors. Current vector manufacturing process is considered highly regulated, elaborate, and expensive. Moreover, at present, there is a shortage of production sites to meet the demand by the pharmaceutical

San Francisco, 26 July 2019:   The Report   Exoskeleton Market   Size, Share & Trends Analysis Report By Type (Mobile, Stationary), By Drive Type, By End-use (Healthcare, Military, Industrial), And Segment Forecasts, 2018 – 2025 The global exoskeleton market is expected to reach USD 3.3 billion by 2025, according to a new report published by Grand View Research. Key factors driving the market expansion include the increasing number of U.S. FDA products, growing demand for exoskeletons in rehabilitation, assisted walking, military applications, and industrial applications. The market is evolving rapidly due to the increasing adoption of exoskeleton technology in the developed regions. The growing geriatric population coupled with increasing number of people suffering with paraplegia, tetraplegia, and other spinal cord injuries are major factors boosting the usage rates of exoskeletons. The exoskeleton market has gained high momentum after the launch of products such as ReWalk

San Francisco, 26 July 2019:   The Report   Internet of Things (IoT) in Healthcare Market   Size, Share & Trends Analysis Report By Component (Service, System & Software), By Connectivity Technology (Satellite, Cellular), By End Use (CRO, Hospital & Clinic), By Application, And Segment Forecasts, 2019 – 2025 The global IoT in healthcare market size is projected to reach USD 534.3 billion by 2025 expanding at a CAGR 19.9% over the forecast period, according to a new report by Grand View Research, Inc. Rise in investments for the implementation of IoT solutions in healthcare sector is one of the key factors driving the market. Increasing penetration of connected devices in various healthcare institutes and adoption of IoT systems and software solutions in healthcare operational activities are also among the key factors augmenting the market growth. Growing preference for real-time data monitoring among the healthcare practitioners to manage chronic diseases is expected t

San Francisco, 26 July 2019:   The Report   Biopsy Devices Market   Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, Competitive Landscape, And Segment Forecasts, 2012 – 2020 The global biopsy devices market size is expected to reach USD 2.3 billion by 2020, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.4% during the forecast period. Growing incidence of cancer, rising geriatric population across the world, and soaring demand for less invasive biopsy procedures are some of the key trends stimulating market growth. Demand for minimally invasive biopsy procedures is rising at a significant rate in the market. Different types of technologies and products such as, biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness high growth during the forecast period. North America is likely to command a consider

San Francisco, 25 July 2019:   The Report   Doxorubicin Market  By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2018 – 2024 The global doxorubicin market was valued at USD 0.81 billion in 2015 and is expected to reach a value of USD 1.38 billion by 2024, according to a new report by Grand View Research, Inc. The growing number of players in the market to control the shortage of the drug is one of the crucial factors that is expected to drive the market in the coming few years. Some of the doxorubicin manufacturers are Ortho Biotech Products, LP, Ben Venue Laboratories, Inc., and Bristol-Myers Squibb Company. The increasing indication of doxorubicin drug in various applications such as AIDS related Kaposi Sarcoma, multiple myeloma, neuroblastoma, osteosarcoma, and ovarian cancer signifies the growth in demand for the drug. The technological advancement in the drug for